Wednesday, April 30, 2014

Health Canada’s Medical Device Bureau Completes Evaluation of SNDY Instruments for Canada

BOSTON, MA, Apr 30, 2014 (eTeligis.com via COMTEX) Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS:SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that Health Canada s Medical Device Bureau (MDB) has completed its initial evaluation of certain Solos Endoscopy instruments and has classified its devices as Class II medical devices. The Medical Device Bureau examined information with respect to the MammoView Dilator Set, MammoView Cytology Retrieval Kit, MammoView Introducer Set, and the Microendoscope Ductoscope. The review was a necessary step in order to determine the appropriate device classification and in turn apply for the Medical Device License with Health Canada. Solos expects to complete the application this week and the Company will await approval for the Medical Device License in the next 30 days. The Company is currently in discussions with Spectrum Medical Market Consultants to act as its regul
http://bit.ly/R0TSYg

No comments:

Post a Comment